Showing papers by "Michael S. Gordon published in 1993"
•
TL;DR: Heterogeneity in responsiveness to steel factor is detected in patients with acute and chronic myeloid leukemia and MDS, and these differences should be carefully considered for possible clinical trials with SLF.
13 citations